Resources
Explore our growing body of resources and research from across the women’s health innovation ecosystem.
Explore
2024
A review on critical appraisal and pathogenesis of polycystic ovarian syndrome
Hajam et al.
Reviews data on the pathogenesis, diagnostic criteria, and multifactorial causes of polycystic ovarian syndrome to inform research and management strategies.
2024
Antiretrovirals in Pregnancy Research Toolkit
World Health Organization
Provides guidance and resources to support inclusion of pregnant and breastfeeding populations in HIV, hepatitis, and STI research, focusing on ethics, study design, and data collection.
2024
B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases
Wang et al.
Summarizes mechanisms and analytical methods for B-cell receptor repertoire diversity and reviews recent research on BCR repertoire in major autoimmune diseases.
2024
Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis Comparing a Short Course of Treatment With the Current South African Standard of Care.
ClinicalTrials.gov
Provides information on a clinical trial to compare the efficacy and safety of a Study Strategy consisting of 6 months of bedaquiline (BDQ), delamanid (DLM), and linezolid (LNZ), with levofloxacin (LVX) and clofazimine (CFZ) compared to the current South African Standard of Care (Control Strategy) for 9 months for the treatment of rifampicin resistant (RR-TB) Tuberculosis.
2024
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021
GBD 2021 Forecasting Collaborators
Provides forecasts and scenario analyses of global disease burden, life expectancy, and risk factor impacts for 204 countries and territories to 2050 to support health policy planning.
2004
Disparities in Infectious Diseases Among Women in Developing Countries
Rashid, J. et al.
Summarizes disparities in infectious disease burden among women in developing countries, highlighting contributing factors and barriers to healthcare access and treatment adherence.
2024
DNA-sensing pathways in health, autoinflammatory and autoimmune diseases
Dong & Fitzgerald
Summarizes DNA-sensing pathways, their regulation, roles in host defense, and how their dysregulation contributes to autoinflammatory and autoimmune diseases, including therapeutic strategies.
2024
Economic Burden Of Community-Acquired Antibiotic-resistant Urinary Tract Infections: Systematic Review And Meta-analysis
Zhu et al.
Synthesizes evidence on the economic, clinical, and health system burden of antibiotic-resistant community-acquired urinary tract infections to inform resource prioritization and intervention evaluation.
2022
Effect of Gender on Clinical Presentation Of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection
Humayun, M. et al.
Provides data on gender differences in TB incidence, clinical presentation, and TB-HIV coinfection in Harare, Zimbabwe, to inform targeted interventions.
2024
Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis
Abara et al.
Summarizes published data on MenB-4C vaccine effectiveness against gonorrhea, including pooled estimates, duration of protection, and implications for vaccine development.
2006
Emerging Infections and Pregnancy
Jamieson, D. J. et al.
Summarizes how pregnancy alters immune response, increasing susceptibility and severity of emerging infectious diseases, to inform clinical and public health planning.
2006
Emerging Infectious Determinants of Chronic Diseases
O’Connor, S. M. et al.
Summarizes evidence linking infectious agents to chronic diseases, outlines mechanisms involved, and highlights implications for prevention and public health research.
2023
Fusobacterium Infection Facilitates the Development of Endometriosis through the Phenotypic Transition of Endometrial Fibroblasts
Muraoka, A. et al.
Provides information on the role of Fusobacterium infection in promoting endometriosis development and suggests antibiotic treatment as a potential therapeutic approach.
2024
Global Tuberculosis Report 2024
World Health Organization
Provides information on global, regional, and country-level TB burden, prevention, diagnosis, treatment, and progress toward international TB targets using WHO-collected data.
2024
Gut microbiota and autoimmune diseases: Insights from Mendelian randomization
Mu et al.
Summarizes Mendelian randomization studies on gut microbiota's causal role in autoimmune diseases to inform diagnosis, prevention, and treatment strategies.
2023
Highly-Specific Single-Stranded Oligonucleotides and Functional Nanoprobes for Clinical Determination of Chlamydia Trachomatis and Neisseria Gonorrhoeae Infections
Dighe et al.
Provides information on the development and validation of rapid, highly specific oligonucleotide-based assays for clinical detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
2024
Limitations of current techniques in clinical antimicrobial resistance diagnosis: examples and future prospects
Hassall et al.
Reviews current and emerging techniques for clinical antimicrobial resistance diagnosis, highlighting limitations and the need for standardisation to improve rapid, accurate detection.
2024
Maternal Vaccination for the Prevention of Infantile RSV Disease: An Overview of the Authorized, In-Progress, and Rejected Vaccine Candidates
Papazisis & Topalidou
Provides an overview of clinical trial data, safety, and outcomes for maternal RSV vaccine candidates to inform prevention and immunization strategies.
2015
Medication Use During Pregnancy, Gestational Age and Date of Delivery: Agreement Between Maternal Self-Reports and Health Database Information in a Cohort
Pisa, F. E. et al.
Provides information on agreement between maternal self-reports and health database data for medication use, gestational age, and delivery timing in pregnancy research.
2014
Microbial Origins of Chronic Diseases
Gargano, L. M. & Hughes, J. M.
Reviews data on associations between microbial agents and chronic diseases, highlighting implications for research, surveillance, treatment, and prevention strategies.
2024
Novel lateral flow assay for point-of-care detection of Neisseria gonorrhoeae infection in syndromic management settings: a cross-sectional performance evaluation
Peters et al.
A cross-sectional study evaluating the performance of the novel N gonorrhoeae lateral flow assay (NG-LFA) at the primary health-care level in South Africa.
2023
Overlooked Sex And Gender Aspects of Emerging Infectious Disease Outbreaks: Lessons Learned from COVID-19 to Move Towards Health Equity in Pandemic Response
Lawry, L. et al.
Reviews sex and gender impacts on emerging infectious disease outbreaks to inform more equitable pandemic preparedness and response strategies.
2024
Pathogenesis of viral infections during pregnancy
Creisher & Klein
Reviews data on the pathogenesis, mechanisms, and outcomes of viral infections during pregnancy, highlighting maternal, fetal, and placental impacts for research and clinical guidance.
2023
Point-of-care tests for sexually transmitted infections: Target product profiles
World Health Organization
Summarizes target product profiles for point-of-care tests for major sexually transmitted infections to guide test development, selection, and implementation.